Clinical Trial Update: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tacrolimus plus mini-methotrexate versus Tacrolimus plus methotrexate for graft-versus-host disease prevention has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Biphenotypic Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Disease
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm
• Non-hodgkin Lymphoma

Drugs mentioned

• Tacrolimus (Tacrolimus)
• mini-methotrexate (methotrexate (mini-dose))

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2023-01-31